Lobbying registrant · LDA.gov number 31350
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1 reportConfirmed from the official record
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAThe registrant lobbying for itself | 2026-Q2: $7,360,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- ANNIE WOERPEL · 1 report
- BART FORSYTH · 1 report
- CATHERINE JANE DOUGLAS · 1 report
- DAVID KORN · 1 report
- ELENORA CONNORS · 1 report
- FABIAN LUCERO · 1 report
- JAKE FREED · 1 report
- JOCELYN ULRICH · 1 report
- JOHN NAPPI · 1 report
- JUDITH HARON · 1 report
- KELLY GOLDBERG · 1 report
- LAUREN JEE · 1 report
- LORI REILLY · 1 report
- MARIA PATTERSON OLSON · 1 report
- MATTHEW JUDE DILORETO · 1 report
- MEREDITH ALLISON · 1 report
- MICHAEL PAUL WOODY · 1 report
- NIELAH TUCKER · 1 report
- RANDY BURKHOLDER · 1 report
- SAMANTHA HELTON ABBOUD · 1 report
- SYLVIA YU · 1 report
- TERESA BILL · 1 report
- TOM O'BRIEN · 1 report
- ZACH SENTEMENTES · 1 report
Bills named, and how the House and the Senate voted
68 bills named in these reports. 7 of them became law, and our record holds how the House and the Senate voted on them. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 4Rescissions Act of 2025 | Became law | Public Law 119-28House 216–213 · Senate 51–48 |
| H.R. 5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 | Became law | Public Law 119-37House 222–209 · Senate 60–40 |
| H.R. 6938Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 | Became law | Public Law 119-74House 397–28 · Senate 82–15 |
| H.R. 7148Consolidated Appropriations Act, 2026 | Became law | Public Law 119-75House 217–214 · Senate 71–29 |
| S. 2Secure America Act | Became law | Public Law 119-98House 214–212 · Senate 52–47 |
| S. 1071National Defense Authorization Act for Fiscal Year 2026 | Became law | Public Law 119-60House 312–112 · Senate 77–20 |
| H.Con.Res. 14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. | Passed both chambers | No recorded vote in our record |
| H.R. 890Stopping Pharma’s Ripoffs and Drug Savings For All Act | Introduced | No recorded vote in our record |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1262Mikaela Naylon Give Kids a Chance Act | Passed the House | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 3152Patent Eligibility Restoration Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3160PREVAIL Act | Introduced | No recorded vote in our record |
| H.R. 3269ETHIC Act | Introduced | No recorded vote in our record |
| H.R. 3521Clinical Trial Modernization Act | Introduced | No recorded vote in our record |
| H.R. 4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 | Introduced | No recorded vote in our record |
| H.R. 4317PBM Reform Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 4570Interagency Patent Coordination and Improvement Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 4780USTRx Act | Introduced | No recorded vote in our record |
| H.R. 5256340B ACCESS Act | Introduced | No recorded vote in our record |
| H.R. 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 | Introduced | No recorded vote in our record |
| H.R. 5342Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 | Introduced | No recorded vote in our record |
| H.R. 6089Biomanufacturing Excellence Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 6423HELP Copays Act | Introduced | No recorded vote in our record |
| H.R. 6485Skinny Labels, Big Savings Act | Introduced | No recorded vote in our record |
| H.R. 6610Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] | Introduced | No recorded vote in our record |
| H.R. 6624Biological Intellectual Property Protection Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 7837Most Favored Patient Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 7953FAIR ACT | Introduced | No recorded vote in our record |
| H.R. 8269CLEAR LABELS Act | Introduced | No recorded vote in our record |
| H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 | Passed the House | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 8845Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9102BINSA Act | Introduced | No recorded vote in our record |
| H.R. 9142Prohibiting Adversarial Patents Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9310Department of Homeland Security Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9661Expedited Access to Biosimilars Act | Introduced | No recorded vote in our record |
| H.Res. 566Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Agreed to in the House | No recorded vote in our record |
| S. 43Skinny Labels, Big Savings Act | Introduced | No recorded vote in our record |
| S. 355FDA Modernization Act 3.0 | Passed the Senate | No recorded vote in our record |
| S. 652Protecting Patients from Deceptive Drug Ads Act | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 864HELP Copays Act | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 1095Stop STALLING Act | Reported by committee | No recorded vote in our record |
| S. 1096Preserve Access to Affordable Generics and Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1097Interagency Patent Coordination and Improvement Act of 2025 | Reported by committee | No recorded vote in our record |
| S. 1387National Biotechnology Initiative Act of 2025 | Introduced | No recorded vote in our record |
| S. 1414Expedited Access to Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1546Patent Eligibility Restoration Act of 2025 | Introduced | No recorded vote in our record |
| S. 1553PREVAIL Act | Introduced | No recorded vote in our record |
| S. 1954Biosimilar Red Tape Elimination Act | Reported by committee | No recorded vote in our record |
| S. 2256Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 | Reported by committee | No recorded vote in our record |
| S. 2276ETHIC Act | Introduced | No recorded vote in our record |
| S. 2296National Defense Authorization Act for Fiscal Year 2026 | Passed the Senate | No recorded vote in our record |
| S. 2354Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 | Reported by committee | No recorded vote in our record |
| S. 2587Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 | Reported by committee | No recorded vote in our record |
| S. 2620REMEDY Act | Introduced | No recorded vote in our record |
| S. 2658Medication Affordability and Patent Integrity Act | Reported by committee | No recorded vote in our record |
| S. 3014Ensuring Timely Access to Generics Act of 2025 | Introduced | No recorded vote in our record |
| S. 3345PBM Price Transparency and Accountability Act | Introduced | No recorded vote in our record |
| S. 3452Biological Intellectual Property Protection Act of 2025 | Introduced | No recorded vote in our record |
| S. 3788CLEAR LABELS Act | Reported by committee | No recorded vote in our record |
| S. 4784National Defense Authorization Act for Fiscal Year 2027 | Reported by committee | No recorded vote in our record |
Issues named: Budget/Appropriations (1), Copyright/Patent/Trademark (1), Health Issues (1), Medicare/Medicaid (1), Trade (domestic/foreign) (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICABudget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom PHRMA BETTER GOVERNMENT COMMITTEE | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom PHRMA BETTER GOVERNMENT COMMITTEE | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.